Literature DB >> 21713395

Randomized clinical trial of postoperative strontium-90 radiation therapy for pterygia: treatment using 30 Gy/3 fractions vs. 40 Gy/4 fractions.

Kiyoshi Nakamatsu1, Yasumasa Nishimura, Shuichi Kanamori, Ryuta Koike, Izumi Tachibana, Tatsuyuki Nishikawa, Toru Shibata.   

Abstract

BACKGROUND AND
PURPOSE: Postoperative adjuvant treatment with strontium-90 radiation therapy (RT) is a proven technique for reducing the recurrence of pterygium. This randomized trial was conducted to evaluate whether a total dose of 40 Gy provides a better local control rate than a total dose of 30 Gy for surgically resected pterygia. PATIENTS AND METHODS: A single institutional randomized trial was conducted. Between 1999 and 2003, 74 pterygia in 71 patients were randomly allocated to 30 Gy/3 fractions/15 days (arm A) or to 40 Gy/4 fractions/22 days (arm B). Only primary pterygia for which RT could be started within 3 days of surgical resection were included. Postoperative RT was given by a strontium-90 eye applicator, and a dose of 10 Gy per fraction was delivered in weekly fractions (day 1, 8, 15, 22).
RESULTS: Of the 74 pterygia treated, 73 in 70 patients were analyzed. Of the 73 pterygia, 41 were allocated to arm A, and the remaining 32 to arm B. The 2-year local control rates for arm A and arm B were 85% and 75%, respectively, without significant difference. No serious acute and late complications were noted in either arm.
CONCLUSION: Our new standard fractionation for postoperative RT for pterygia is 30 Gy/3 fractions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21713395     DOI: 10.1007/s00066-011-2212-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  30 in total

1.  Analysis of intrathoracic tumor mobility during whole breathing cycle by dynamic MRI.

Authors:  Christian Plathow; Sebastian Ley; Christian Fink; Michael Puderbach; Waldemar Hosch; Astrid Schmähl; Jürgen Debus; Hans-Ulrich Kauczor
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

2.  Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.

Authors:  Matthias Guckenberger; Sami Ok; Bülent Polat; Reinhart A Sweeney; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

3.  MRI/linac integration.

Authors:  Jan J W Lagendijk; Bas W Raaymakers; Alexander J E Raaijmakers; Johan Overweg; Kevin J Brown; Ellen M Kerkhof; Richard W van der Put; Björn Hårdemark; Marco van Vulpen; Uulke A van der Heide
Journal:  Radiother Oncol       Date:  2007-11-26       Impact factor: 6.280

4.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

Authors:  Stephanie T H Peeters; Wilma D Heemsbergen; Peter C M Koper; Wim L J van Putten; Annerie Slot; Michel F H Dielwart; Johannes M G Bonfrer; Luca Incrocci; Joos V Lebesque
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

5.  Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials.

Authors:  Reinhold Graf; Dirk Boehmer; Volker Budach; Peter Wust
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

6.  Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI).

Authors:  Michel J Ghilezan; David A Jaffray; Jeffrey H Siewerdsen; Marcel Van Herk; Anil Shetty; Michael B Sharpe; Syed Zafar Jafri; Frank A Vicini; Richard C Matter; Donald S Brabbins; Alvaro A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

7.  Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.

Authors:  Jeff M Michalski; Kyounghwa Bae; Mack Roach; Arnold M Markoe; Howard M Sandler; Janice Ryu; Matthew B Parliament; William Straube; Richard K Valicenti; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

8.  4D-MRI analysis of lung tumor motion in patients with hemidiaphragmatic paralysis.

Authors:  Julien Dinkel; Christian Hintze; Ralf Tetzlaff; Peter E Huber; Klaus Herfarth; Juergen Debus; Hans U Kauczor; Christian Thieke
Journal:  Radiother Oncol       Date:  2009-04-24       Impact factor: 6.280

9.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.

Authors:  Michael J Zelefsky; Emily J Levin; Margie Hunt; Yoshiya Yamada; Alison M Shippy; Andrew Jackson; Howard I Amols
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-15       Impact factor: 7.038

10.  Intrafraction motion of the prostate during an IMRT session: a fiducial-based 3D measurement with Cone-beam CT.

Authors:  Judit Boda-Heggemann; Frederick Marc Köhler; Hansjörg Wertz; Michael Ehmann; Brigitte Hermann; Nadja Riesenacker; Beate Küpper; Frank Lohr; Frederik Wenz
Journal:  Radiat Oncol       Date:  2008-11-05       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.